| Jun 4 |
Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer
|
| Jun 3 |
Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials
|
| May 31 |
Guardant Health Named to TIME100 Most Influential Companies
|
| May 30 |
Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening
|
| May 30 |
Cathie Wood-LedArk Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
|
| May 27 |
Guardant Health (GH) Recently Broke Out Above the 200-Day Moving Average
|
| May 24 |
Evaluating Guardant Health: Insights From 5 Financial Analysts
|
| May 24 |
Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests
|
